Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.1261
-0.0007 (-0.55%)
May 14, 2025, 12:54 PM - Market open
Petros Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 3.71 | 13.34 | 9.43 | 23.85 | 17.14 | Upgrade
|
| Cash & Short-Term Investments | 3.71 | 13.34 | 9.43 | 23.85 | 17.14 | Upgrade
|
| Cash Growth | -72.18% | 41.49% | -60.47% | 39.14% | 698.75% | Upgrade
|
| Accounts Receivable | 0.42 | 2.23 | 2.11 | 2.46 | 5.15 | Upgrade
|
| Other Receivables | - | - | - | 0.61 | - | Upgrade
|
| Receivables | 0.42 | 2.23 | 2.11 | 3.06 | 5.15 | Upgrade
|
| Inventory | 3 | 2.79 | 1.82 | 0.52 | 0.76 | Upgrade
|
| Prepaid Expenses | 0.16 | 1.22 | 0.51 | 1.58 | 1.37 | Upgrade
|
| Other Current Assets | 0.01 | 0.82 | 0.8 | 1.53 | 1.48 | Upgrade
|
| Total Current Assets | 7.29 | 20.39 | 14.67 | 30.54 | 25.91 | Upgrade
|
| Property, Plant & Equipment | 0.14 | 0.26 | 0.4 | 0.52 | 0.64 | Upgrade
|
| Other Intangible Assets | 3.2 | 8.97 | 12.24 | 25.29 | 32.16 | Upgrade
|
| Other Long-Term Assets | - | 4.18 | 5.11 | 11.03 | 11.14 | Upgrade
|
| Total Assets | 10.64 | 33.8 | 32.42 | 67.39 | 69.85 | Upgrade
|
| Accounts Payable | 2.33 | 1.71 | 1.81 | 4.56 | 5.61 | Upgrade
|
| Accrued Expenses | 1.29 | 1.18 | 1.32 | 3.5 | 2.96 | Upgrade
|
| Current Portion of Long-Term Debt | 7.25 | 1.16 | 1.09 | - | 7.18 | Upgrade
|
| Current Portion of Leases | 0.06 | 0.13 | 0.14 | 0.13 | 0.11 | Upgrade
|
| Other Current Liabilities | 7.1 | 6.59 | 2.71 | 22.8 | 26.04 | Upgrade
|
| Total Current Liabilities | 18.03 | 10.77 | 7.07 | 30.98 | 41.89 | Upgrade
|
| Long-Term Debt | - | 6.86 | 8.39 | - | - | Upgrade
|
| Long-Term Leases | 0.08 | 0.14 | 0.26 | 0.41 | 0.53 | Upgrade
|
| Other Long-Term Liabilities | - | 3.55 | 0 | 0.46 | 9.96 | Upgrade
|
| Total Liabilities | 18.1 | 21.32 | 15.72 | 31.85 | 52.38 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 105.74 | 110.96 | 107.43 | 106.23 | 79.17 | Upgrade
|
| Retained Earnings | -113.21 | -98.89 | -90.73 | -70.69 | -61.7 | Upgrade
|
| Total Common Equity | -7.47 | 12.07 | 16.7 | 35.54 | 17.47 | Upgrade
|
| Shareholders' Equity | -7.47 | 12.48 | 16.7 | 35.54 | 17.47 | Upgrade
|
| Total Liabilities & Equity | 10.64 | 33.8 | 32.42 | 67.39 | 69.85 | Upgrade
|
| Total Debt | 7.39 | 8.28 | 9.88 | 0.53 | 7.81 | Upgrade
|
| Net Cash (Debt) | -3.68 | 5.06 | -0.46 | 23.32 | 9.33 | Upgrade
|
| Net Cash Growth | - | - | - | 150.05% | - | Upgrade
|
| Net Cash Per Share | -11.45 | 58.14 | -5.51 | 535.30 | 436.51 | Upgrade
|
| Filing Date Shares Outstanding | 2.14 | 0.28 | 0.08 | 0.08 | 0.04 | Upgrade
|
| Total Common Shares Outstanding | 0.42 | 0.12 | 0.08 | 0.08 | 0.04 | Upgrade
|
| Working Capital | -10.73 | 9.62 | 7.6 | -0.44 | -15.99 | Upgrade
|
| Book Value Per Share | -17.73 | 100.88 | 200.81 | 429.60 | 449.87 | Upgrade
|
| Tangible Book Value | -10.67 | 3.1 | 4.46 | 10.25 | -14.69 | Upgrade
|
| Tangible Book Value Per Share | -25.34 | 25.90 | 53.60 | 123.91 | -378.35 | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.